|
|
Professor Jin Shi’s experience in treating arthralgia syndrome with rattan drugs |
CHEN Quan1 SUN Lixia1 ZHOU Nan2 YANG Haoran1 LIU Lina1 |
1.Department of Infectious Diseases, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province, Nanjing 210029, China;
2.Department of Encephalopathy, the Second Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province, Nanjing 210017, China |
|
|
Abstract Impediment is due to wind, cold, dampness, heat and other evil qi blocking channel-collateral, resulting in limb bones, joints, muscles and other areas of pain, heavy, sour, numbness, or joint flexion and extension adverse, stiffness, swelling, deformation, and so on as the main disease. The disease is lingering and difficult to heal, long-term oral Western medicine treatment is easy to lead to a variety of adverse reactions, is a clinical syndrome of knotty. Professor Jin Shi believes that impediment can be divided into wind, cold, dampness, and heat pathogen partial victory. On the basis of treatment based on syndrome differentiation, impediment disease can be treated by different nature, flavour, channel tropism and function characteristics of rattan drugs. Kadsura pepper stem and common clubmoss herb can be used to treat migratory impediment, suberect spatholobus stem and piper wallichii can be used to treat painful impediment, orientvine vine and dutchmanspipe vine can be used to treat fixed arthralgia, honeysuckle stem, Chinese starjasmine stem, and Tripterygium wilfordii can be used to treat heat impediment, and the clinical effect is significant. In this paper, professor Jin Shi’s experience is summarized and discussed, and a medical case is attached for evidence, so as to enrich the clinical diagnosis and treatment ideas of impediment.
|
|
|
|
|
[1] 薛博瑜,吴伟.中医内科学[M].北京:人民卫生出版社,2016:349-350.
[2] 李忠民.抗类风湿疾病药物不良反应研究进展[J].黑龙江医药,2018,31(5):985-987.
[3] 陈涛,徐浩,施杞,等.海风藤治疗类风湿关节炎的网络药理学研究[J].中药新药与临床药理,2020,31(2):192-198.
[4] 胡隽.海风藤油止痛温控贴膏剂的制备工艺及其质量控制研究[D].武汉:湖北中医药大学,2019.
[5] 刘静,年华,徐熠,等.伸筋草生物碱对佐剂性关节炎大鼠的抗炎作用及机制研究[J].药物评价研究,2019,42(5):869-872.
[6] 刘静,王晓静,戴忠,等.鸡血藤研究进展[J].中国药事,2019,33(2):188-194.
[7] 谭静,林红强,王涵,等.鸡血藤的药理作用及临床应用研究进展[J].中药与临床,2018,9(5):61-65.
[8] 吴鹏,单进军,黄正泉,等.丁公藤对大鼠膝骨关节炎滑膜炎症及痛阈的影响[J].南京中医药大学学报,2020,36(6):837-841.
[9] 胡静,杨媛媛,任慧,等.光叶丁公藤中化学成分的UPLC-Q-Exactive Focus-MS/MS鉴定[J].中国实验方剂学杂志,2020,26(18):124-132.
[10] 闫翔.青风藤治疗类风湿关节炎溯源及临床应用存在问题探讨[J].西南军医,2020,22(5):437-438.
[11] 邹文静,董昭阳,黄朝旭,等.基于网络药理学预测青风藤治疗类风湿关节炎的分子机制[J].临床医学研究与实践,2021,6(1):1-4.
[12] 李静,韩燕雨.忍冬非花蕾部位的研究进展[J].中华中医药学刊,2020,38(4):43-50.
[13] 魏英俊,侯璇,徐克武,等.中药复方治疗湿热型痛风性关节炎临床及作用机制研究进展[J].中国现代应用药学,2020,37(18):2299-2304.
[14] 刘孟敏,马勇,郭杨.骨伤科常用藤类中药的研究进展[J].中国中医骨伤科杂志,2020,28(1):86-88.
[15] 马珂,周胜强,邱四君,等.基于数据挖掘的国医大师刘祖贻治疗类风湿关节炎用药规律研究[J].湖南中医药大学学报,2019,39(1):11-15.
[16] 龙洁,王涛,曲晨,等.雷公藤多苷片联合甲氨蝶呤治疗类风湿性关节炎的效果[J].中国医药导报,2019,16(7):71-75.
[17] 姜淼,张海波,丁樱.雷公藤多苷药理作用及临床应用研究进展[J].中华中医药学刊,2021,39(3):59-63.
[18] 李玲,王莘智.从寒热辨证探讨雷公藤片对类风湿性关节炎的临床疗效[J].亚太传统医药,2020,16(3):140-143.
[19] 洪浩,杜伟锋,朱伟豪,等.中药脏器毒性研究进展[J].中华中医药杂志,2021,36(2):943-946.
[20] 石小培,胡秋红,黄柏学,等.中药单药有效成分治疗非酒精性脂肪肝作用机制研究进展[J].中医药导报,2019, 25(15):114-117.
[21] 李文怡,袁成民.非酒精性脂肪性肝病的中西医治疗[J].临床肝胆病杂志,2020,36(4):919-923.
[22] 梁明辉.中药虎杖的研究进展[J].中国医药指南,2019, 17(10):47,54.
[23] 王彬,杨郎.四逆散合四君子汤加香附元胡台乌砂仁治疗胃脘痛的疗效观察[J].中医临床研究,2020,12(11):64-66.
[24] 陈甜甜,袁捷,陈杰,等.基于数据挖掘分析《中国百年百名中医临床家丛书》中关节痹痛的用药规律[J].中国医药导报,2021,18(3):151-155,176.
[25] 张仪美,王永成,贾红玲,等.中医药及民族医药治疗膝骨关节炎的研究[J].西部中医药,2019,32(11):154-157.
[26] 王一全,高明利,膝骨关节炎中西医诊治研究进展[J].实用中医内科杂志,2021,35(3):8-12.
[27] 张学平,金钰,邵宏伟,等.血清LncRNA MEG3、miR-141表达对类风湿性关节炎诊断价值分析[J].疑难病杂志,2021,20(1):72-76.
[28] 韩宇飞,高明利,刘东武.类风湿性关节炎的发病机制研究进展综述[J].中国卫生标准管理,2021,12(1):162-165. |
|
|
|